DK1094791T3 - Thixotropiske formuleringer til fyldning af gelatinekapsler - Google Patents

Thixotropiske formuleringer til fyldning af gelatinekapsler

Info

Publication number
DK1094791T3
DK1094791T3 DK99929399T DK99929399T DK1094791T3 DK 1094791 T3 DK1094791 T3 DK 1094791T3 DK 99929399 T DK99929399 T DK 99929399T DK 99929399 T DK99929399 T DK 99929399T DK 1094791 T3 DK1094791 T3 DK 1094791T3
Authority
DK
Denmark
Prior art keywords
filling
compositions
consistency
gelatin capsules
pasty
Prior art date
Application number
DK99929399T
Other languages
Danish (da)
English (en)
Inventor
Pascal Lombardin
Jean-Louis Grossiord
Monique Seiller
Elie Leverd
Eric Goutay
Jooel Bougaret
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Application granted granted Critical
Publication of DK1094791T3 publication Critical patent/DK1094791T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
DK99929399T 1998-07-07 1999-07-05 Thixotropiske formuleringer til fyldning af gelatinekapsler DK1094791T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9808664A FR2781373B1 (fr) 1998-07-07 1998-07-07 Formulations thixotropes pour le remplissage de gelules
PCT/FR1999/001614 WO2000001371A1 (fr) 1998-07-07 1999-07-05 Formulations thixotropes pour le remplissage de gelules

Publications (1)

Publication Number Publication Date
DK1094791T3 true DK1094791T3 (da) 2003-08-11

Family

ID=9528339

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99929399T DK1094791T3 (da) 1998-07-07 1999-07-05 Thixotropiske formuleringer til fyldning af gelatinekapsler

Country Status (15)

Country Link
US (1) US6709675B1 (de)
EP (1) EP1094791B1 (de)
JP (1) JP2002519370A (de)
CN (1) CN1211124C (de)
AT (1) ATE237318T1 (de)
AU (1) AU760665B2 (de)
BR (1) BR9911905A (de)
CA (1) CA2337273A1 (de)
DE (1) DE69906974T2 (de)
DK (1) DK1094791T3 (de)
ES (1) ES2197647T3 (de)
FR (1) FR2781373B1 (de)
PT (1) PT1094791E (de)
WO (1) WO2000001371A1 (de)
ZA (1) ZA200100052B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002340847B2 (en) * 2001-09-10 2007-09-13 F. Hoffmann-La Roche Ag Oily thixotropic formulations
US7109247B2 (en) 2003-05-30 2006-09-19 3M Innovative Properties Company Stabilized particle dispersions containing nanoparticles
US20040242729A1 (en) * 2003-05-30 2004-12-02 3M Innovative Properties Company Stabilized particle dispersions containing surface-modified inorganic nanoparticles
US7459146B2 (en) 2003-05-30 2008-12-02 3M Innovative Properties Company Stabilized aerosol dispersions
EP1645268A1 (de) * 2003-06-27 2006-04-12 Wakunaga Pharmaceutical Co., Ltd. Hartkapsel
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
US8318210B2 (en) 2005-02-28 2012-11-27 Neos Therapeutics, Lp Compositions and methods of making sustained release liquid formulations
WO2006132307A1 (ja) 2005-06-10 2006-12-14 Pierre Fabre Medicament S.A. 安定化されたミルナシプラン製剤
CN100335135C (zh) * 2005-11-04 2007-09-05 天津太平洋制药有限公司 银杏叶提取物胶囊组合物及其制备方法
US20080319083A1 (en) * 2006-01-27 2008-12-25 Asahi Kasei Pharma Corporation Medicine for transnasal administration
EP2121901A4 (de) * 2007-01-16 2010-03-24 Univ Texas Tech System Verfahren und vorrichtung zur geschlechtswahl auf ph-basis
DE102007055341A1 (de) * 2007-11-19 2009-05-20 Bayer Animal Health Gmbh Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren
WO2011151087A1 (en) * 2010-06-02 2011-12-08 Astellas Deutschland Gmbh Oral dosage forms of bendamustine
US8978783B2 (en) 2011-05-26 2015-03-17 Smith International, Inc. Jet arrangement on an expandable downhole tool
EP3100721B1 (de) * 2014-01-31 2020-08-26 Fuji Capsule Co., Ltd. Kapselformulierung
DE102016109669A1 (de) 2016-05-25 2017-11-30 Tiernahrung Deuerer Gmbh Verfahren zum Herstellen eines Tiernahrungsproduktes
KR20200072479A (ko) 2017-10-19 2020-06-22 사인패스 파마 인코포레이티드 채널병증을 야기하는 약물에 대한 DMPC, DMPG, DMPC/DMPG, LysoPG 및 LysoPC의 보호 효과

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4202888A (en) * 1976-07-12 1980-05-13 Kali-Chemie Pharma Gmbh. Readily enterally absorbable pharmaceutical compositions of cardiac glycosides and preparation thereof
USH672H (en) * 1986-12-31 1989-09-05 E. R. Squibb & Sons, Inc. Stable antifungal capsule formulation
DE59004243D1 (de) * 1990-06-14 1994-02-24 Henning Berlin Gmbh Flüssig befüllte Steckkapselpräparate.
IL102003A0 (en) * 1991-06-03 1992-12-30 Merck Sharp & Dohme Pharmaceutical formulation of a benzodiazepine
GB9325445D0 (en) * 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
US5545628A (en) * 1995-01-10 1996-08-13 Galephar P.R. Inc. Pharmaceutical composition containing fenofibrate
EP0833621B1 (de) * 1995-06-09 2002-01-30 R.P. Scherer Technologies, Inc. Weichgelatinekapsel mit teilchenmaterial
US5993858A (en) * 1996-06-14 1999-11-30 Port Systems L.L.C. Method and formulation for increasing the bioavailability of poorly water-soluble drugs
TW426516B (en) * 1996-12-06 2001-03-21 Fujisawa Pharmaceutical Co An oral pharmaceutical composition in solid dispersion containing water-insoluble tricyclic compounds
FR2761265B1 (fr) * 1997-03-28 1999-07-02 Sanofi Sa Composition pharmaceutique pour l'administration orale d'un derive du n-piperidino-3-pyrazolecarboxamide, de ses sels et de leurs solvates
US6171615B1 (en) * 1998-07-06 2001-01-09 Gattefoss{acute over (e)} Sustained release theophylline formulations, excipient systems and methods of production
US6365181B1 (en) * 2000-04-20 2002-04-02 Gattefosse Corporation Thixatropic gelatin carrier composition

Also Published As

Publication number Publication date
FR2781373B1 (fr) 2001-09-21
AU760665B2 (en) 2003-05-22
EP1094791A1 (de) 2001-05-02
CN1308522A (zh) 2001-08-15
CA2337273A1 (fr) 2000-01-13
WO2000001371A1 (fr) 2000-01-13
ATE237318T1 (de) 2003-05-15
PT1094791E (pt) 2003-08-29
JP2002519370A (ja) 2002-07-02
EP1094791B1 (de) 2003-04-16
ES2197647T3 (es) 2004-01-01
DE69906974T2 (de) 2004-02-26
BR9911905A (pt) 2001-03-27
DE69906974D1 (de) 2003-05-22
FR2781373A1 (fr) 2000-01-28
US6709675B1 (en) 2004-03-23
AU4622799A (en) 2000-01-24
CN1211124C (zh) 2005-07-20
ZA200100052B (en) 2001-07-16

Similar Documents

Publication Publication Date Title
DK1094791T3 (da) Thixotropiske formuleringer til fyldning af gelatinekapsler
ATE235235T1 (de) Arzneistoffverabreichungssystem auf basis von flüssigkristall-strukturen
Ma et al. Multiple water-in-oil-in-water emulsion gels based on self-assembled saponin fibrillar network for photosensitive cargo protection
EE200300109A (et) Protsess vedela emulsioonkompositsiooni valmistamiseks ja emulsiooni kontsentraadi valmistamiseks, farmatseutiline kompositsioon, emulsiooni kontsentraat, komplekt ja emulsioonkompositsioon
ECSP067062A (es) Derivados de pirazol, composiciones que contienen dichos compuestos y procedimientos de uso
UY29701A1 (es) Formulaciones líquidas para la administración controlada de derivados de bencisoxazol
SV2004001556A (es) Preparaciones acidas de insulina con establidad mejorada
EA200601588A1 (ru) Стабилизированные перенасыщенные твёрдые растворы липофильных лекарственных средств
ES2173708T3 (es) Composicion filmogena que comprende un poliuretano en dispersion acuosa y un agente plastificante.
TW200605882A (en) Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof
ES2172003T3 (es) Formulacion oral de liberacion retardada inmediata y metodo para su preparacion.
WO2004052336A3 (en) High viscosity liquid controlled delivery system and medical or surgical device
WO2001015734A3 (en) High viscosity liquid controlled delivery system and medical or surgical device
EA200702320A1 (ru) Соединения trpv1 агониста и способы их получения и применения
Majumder et al. Hydroxy propyl methyl cellulose: different aspects in drug delivery
NZ730571A (en) Pharmaceutical compositions having improved storage stability
DK1952142T3 (da) Opløsningssammensætning til undersøgelse af lægemiddelopløselighed
AR084524A1 (es) Un metodo para microencapsular un principio activo con una matriz enterica y las composiciones particuladas microencapsuladas asi preparadas
Szűts et al. Study of the effects of drugs on the structures of sucrose esters and the effects of solid-state interactions on drug release
ATE293964T1 (de) Zusammensetzungen und verfahren zur behinderung der entladung von nematokyste
WO2005025469A8 (en) Cold pack
DK0521353T3 (da) Lægemiddel med antineoplastisk virkning, der som virksomt stof indeholder octadecyl-(2-(N-metylpiperidino)-ethyl)-phosphat og fremgangsmåde til fremstilling deraf
DE60120630D1 (de) Pharmazeutische Zusammensetzung enthaltend Xanthangummi
DK1144420T3 (da) Sulfaterede phosphatidylinositoler, fremgangsmåde til fremstilling heraf og anvendelser heraf
JPS649932A (en) Soft capsule preparation using newly combined component as the base